Artificial Intelligence in Drug Discovery Market: In-Depth Market Analysis, Trends & 2026 Outlook

The Artificial Intelligence in Drug Discovery Market has transitioned from experimental curiosity to strategic necessity. A decade ago, AI-driven drug discovery felt like a promising research project. Today, it sits at the core of pharmaceutical R&D transformation.

Pharmaceutical companies face rising R&D costs, long development timelines, and high clinical failure rates. According to the U.S. Food and Drug Administration (FDA) and multiple industry analyses, only a small percentage of drug candidates entering clinical trials ultimately receive approval. This efficiency gap creates strong demand for computational approaches that can improve target identification, molecule design, and clinical success prediction.

Get More Info:https://www.transpireinsight.com/report/artificial-intelligence-in-drug-discovery-market